Treatable glomerular hyperfiltration in patients with active acromegaly.

OBJECTIVE The glomerular filtration rate (GFR) is increased in patients with active acromegaly. The aim of this study is to elucidate whether renal function deteriorates in patients with acromegaly and whether this deterioration is reversible after surgical remission. DESIGN/METHODS A case-control study of 48 acromegalic patients who were surgically cured (cases) and 48 patients with nonfunctioning pituitary adenomas (NFomas, controls) was conducted. We performed clinical and biochemical examinations before surgery and 3months post-surgery. The GFR of each patient was estimated (estimated GFR, eGFR) using their serum creatinine, age, sex, and body surface area, and postoperative changes in the eGFR were assessed. RESULTS The preoperative eGFR was significantly higher in patients with acromegaly than in those with NFoma (99.8 vs 75.1mL/min respectively, P<0.01). In acromegalic patients, surgical remission was accompanied by a significant decline in the eGFR (from 99.8 to 86.2mL/min, P<0.01). Conversely, in patients with NFoma, the postoperative eGFR did not change significantly (from 75.1 to 81.9mL/min, P=0.12). Among the acromegalic patients, the postoperative decreases in the eGFR were more prominent in patients with a preoperatively high or normal vs low eGFR. CONCLUSIONS Our data demonstrated a significant post-surgical eGFR decrease in patients with acromegaly, but not in patients with NFomas. This change in the eGFR was reversible in acromegalic patients with a high/normal preoperative eGFR, but not in those with a low preoperative eGFR. This suggests that the reversible pathophysiological change in some patients is functional but not organic.

[1]  Ji-Eun Kim,et al.  Clinical Usefulness of Serum Cystatin C as a Marker of Renal Function , 2014, Diabetes & metabolism journal.

[2]  R. Bernays,et al.  Impact of Growth Hormone on Cystatin C , 2013, Nephron Extra.

[3]  G. Stalla,et al.  Somatostatin receptors: From signaling to clinical practice , 2013, Frontiers in Neuroendocrinology.

[4]  A. Levin,et al.  Practice Guideline , 2020, Encyclopedia of Behavioral Medicine.

[5]  J. Sarnthein,et al.  Soluble α-klotho: a novel serum biomarker for the activity of GH-producing pituitary adenomas. , 2013, European journal of endocrinology.

[6]  K. Chihara,et al.  Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS method. , 2012, Endocrine journal.

[7]  D. Chauveau,et al.  Impact of growth hormone hypersecretion on the adult human kidney. , 2011, Annales d'endocrinologie.

[8]  M. D. De Martino,et al.  The kidney in acromegaly: renal structure and function in patients with acromegaly during active disease and 1 year after disease remission. , 2010, European journal of endocrinology.

[9]  Yasuhiko Tomino,et al.  Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  J. Scholey,et al.  Insights into the regulation of renal hemodynamic function in diabetic mellitus. , 2008, Current diabetes reviews.

[11]  S. Melmed Medical progress: Acromegaly. , 2006, The New England journal of medicine.

[12]  F. Schaefer,et al.  Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling , 2005, Pediatric Nephrology.

[13]  A. Flyvbjerg,et al.  The physiological and pathophysiological roles of the GH/IGF-axis in the kidney: lessons from experimental rodent models. , 2004, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[14]  S. Prahalada,et al.  Morphological Changes in the Kidney of Dogs Chronically Exposed to Exogenous Growth Hormone , 2000, Toxicologic pathology.

[15]  F. Casanueva,et al.  Criteria for cure of acromegaly: a consensus statement. , 2000, The Journal of clinical endocrinology and metabolism.

[16]  J. Floege,et al.  Effects of rhGH and rhIGF-1 on renal growth and morphology. , 1993, Kidney international.

[17]  L. Sjöström,et al.  Adipose tissue and muscle volume determination by computed tomography in acromegaly, before and I year after adenomectomy , 1993, European journal of clinical investigation.

[18]  B. Tönshoff,et al.  Growth hormone-induced glomerular hyperfiltration is dependent on vasodilating prostanoids. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  D. Layish,et al.  Growth hormone and the kidney: a case presentation and review of the literature. , 1992, Journal of the American Society of Nephrology : JASN.

[20]  R. Dullaart,et al.  Effect of a somatostatin analogue, octreotide, on renal haemodynamics and albuminuria in acromegalic patients , 1992, European journal of clinical investigation.

[21]  D. Haffner,et al.  The acute effect of growth hormone on GFR is obliterated in chronic renal failure. , 1989, Clinical nephrology.

[22]  M. Carey,et al.  A simple method for assessment of glomerular size and its use in the study of kidneys in acromegaly and compensatory renal enlargement , 1989, The Journal of pathology.

[23]  E. Froesch,et al.  Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Kopple,et al.  The delayed effect of growth hormone on renal function in humans. , 1989, Kidney international.

[25]  R. Palmiter,et al.  Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1. , 1988, The American journal of pathology.

[26]  T. Adrian,et al.  Electrophysiological actions of somatostatin on the atrioventricular junction in sinus rhythm and reentry tachycardia. , 1986, British heart journal.

[27]  B. Brenner Nephron adaptation to renal injury or ablation. , 1985, The American journal of physiology.

[28]  J. Polak,et al.  Somatostatin in the human heart and comparison with guinea pig and rat heart. , 1985, British heart journal.

[29]  J. Christiansen,et al.  Kidney function and size in normal subjects before and during growth hormone administration for one week , 1981, European journal of clinical investigation.

[30]  T. Falkheden,et al.  RENAL FUNCTION AND KIDNEY SIZE FOLLOWING HYPOPHYSECTOMY IN MAN. , 1965, Acta endocrinologica.

[31]  J. Corvilain,et al.  Some effects of human growth hormone on renal hemodynamics and on tubular phosphate transport in man. , 1962, The Journal of clinical investigation.

[32]  H. Gershberg,et al.  Renal function studies and autopsy report in a patient with gigantism and acromegaly. , 1957, The Journal of clinical endocrinology and metabolism.

[33]  R. Luft,et al.  Glomerular filtration rate and renal plasma flow in acromegaly. , 1956, Acta endocrinologica.

[34]  R. Luft,et al.  The significance of the adenohypophysis, adrenal cortex and thyroid in renal function in man. , 1950, Acta endocrinologica.